Exploiting Zebrafish Xenografts for Testing the in vivo Antitumorigenic Activity of Microcin E492 Against Human Colorectal Cancer Cells
One of the approaches to address cancer treatment is to develop new drugs not only to obtain compounds with less side effects, but also to have a broader set of alternatives to tackle the resistant forms of this pathology. In this regard, growing evidence supports the use of bacteria-derived peptide...
Main Authors: | Macarena A. Varas, Carlos Muñoz-Montecinos, Violeta Kallens, Valeska Simon, Miguel L. Allende, Andrés E. Marcoleta, Rosalba Lagos |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2020.00405/full |
Similar Items
-
The Green Tea Polyphenol Epigallocatechin-Gallate (EGCG) Interferes with Microcin E492 Amyloid Formation
by: Paulina Aguilera, et al.
Published: (2023-10-01) -
Identification of key amino acid residues modulating intracellular and in vitro microcin E492 amyloid formation
by: Paulina eAguilera, et al.
Published: (2016-01-01) -
Antibacterial Activity of the Peptide Microcin J25 Produced by Escherichia coli
by: Saman Shalibeik, et al.
Published: (2022-05-01) -
Microcins in Enterobacteriaceae: Peptide Antimicrobials in the Eco-Active Intestinal Chemosphere
by: Fernando Baquero, et al.
Published: (2019-10-01) -
Autoinducer-2 Quorum Sensing Contributes to Regulation of Microcin PDI in Escherichia coli
by: Shao-Yeh Lu, et al.
Published: (2017-12-01)